Merck (MRK) Non-Current Assets (2009 - 2026)

Merck (MRK) has reported Non-Current Assets for 18 consecutive years, with $125.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Non-Current Assets fell 99.84% year-over-year to $125.0 million in Q2 2026; TTM through Jun 2026 was $125.0 million, a 99.96% decrease from a year earlier, with the FY2025 full-year figure at $125.0 million, changed N/A from the prior year.
• Non-Current Assets was $125.0 million for Q2 2026 at Merck, roughly flat from $125.0 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $82.0 billion in Q3 2025 and troughed at $125.0 million in Q4 2025.
• A 5-year average of $62.6 billion and a median of $74.5 billion in 2023 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets advanced 20.89% in 2022 and slumped 99.84% in 2026, its largest moves.
• Over 5 years, Non-Current Assets stood at $73.4 billion in 2022, then climbed by 1.46% to $74.5 billion in 2023, then grew by 3.58% to $77.2 billion in 2024, then slumped by 99.84% to $125.0 million in 2025, then changed by 0.0% to $125.0 million in 2026.
• The last three Non-Current Assets figures came in at $125.0 million (Q2 2026), $125.0 million (Q1 2026), and $125.0 million (Q4 2025), per Business Quant data.